Location History:
- Horsham, GB (2013)
- Fareham, GB (2013)
- Hants, GB (2015)
Company Filing History:
Years Active: 2013-2015
Title: The Innovative Contributions of Cathy Ritchie
Introduction
Cathy Ritchie is a prominent inventor based in Hants, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors involved in various diseases. With a total of 3 patents to her name, Ritchie continues to push the boundaries of innovation in her field.
Latest Patents
Cathy Ritchie's latest patents include groundbreaking work on imidazo-pyridine derivatives. These compounds serve as activin-like receptor kinase (ALK4 or ALK5) inhibitors, which are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. The patents describe pharmaceutical compositions that contain these compounds and processes for their preparation. Additionally, she has developed inhibitors of phosphatidylinositol 3-kinase, which are also useful for treating conditions mediated by this kinase. These compounds are presented in free or salt form, with specific structural formulas detailed in the specifications.
Career Highlights
Cathy Ritchie is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative pharmaceutical solutions that address critical health challenges. Ritchie's expertise in medicinal chemistry and her dedication to research have positioned her as a key player in her field.
Collaborations
Cathy has collaborated with notable colleagues, including Duncan Shaw and Nikolaus Johannes Stiefl. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Cathy Ritchie's contributions to the field of pharmaceuticals exemplify her commitment to innovation and excellence. Her patents reflect her dedication to improving healthcare through scientific advancements.